Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Belcher Pharmaceuticals, LLC v. Hospira, Inc.
Case Number:
1:17-cv-00775
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
February 04, 2022
Belcher Must Cover Hospira's Legal Fees In Patent Fight
A Delaware federal judge has ordered Belcher Pharmaceuticals to foot the bill for Pfizer unit Hospira in Belcher's patent infringement suit over epinephrine injector Abboject, finding that the accuser's antics during the litigation — and the "weak" suit it lodged — called for the company to cover Hospira's fees.
-
April 01, 2020
Pfizer Gets Rival's Epinephrine Injection Patent Killed
Belcher Pharmaceuticals LLC's attempt to hold a Pfizer Inc. unit responsible for patent infringement with its new epinephrine injector Abboject failed this week, when U.S. District Judge Leonard P. Stark instead invalidated the company's patent following a bench trial.